3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
4
Lymphoma
3
Hodgkin Disease
3
Recurrence
2
Lymphoma, Mantle-Cell
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Burkitt Lymphoma
2
Uveal Melanoma
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Plasmablastic Lymphoma
1
Pediatric Brain Tumor
1
Oligodendroglioma
1
Neoplasms
1
Lymphoma, T-Cell, Peripheral
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, T-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Immunoblastic Lymphadenopathy
1
HIV Infections
1
Glioblastoma
1
Enteropathy-Associated T-Cell Lymphoma
1
Brain Neoplasms
1
Astrocytoma
1
Interventions
asciminib
15
Cyclophosphamide
12
fludarabine phosphate
10
Mycophenolic Acid
9
fludarabine
8
nilotinib
7
Whole-Body Irradiation
7
Imatinib Mesylate
6
Tacrolimus
5
Sirolimus
5
Dasatinib
5
Cyclosporine
5
bosutinib
4
Melphalan
4
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
Granulocyte Colony-Stimulating Factor
3
Cyclosporins
3
Busulfan
3
venetoclax
2
thymoglobulin
2
ruxolitinib
2
ponatinib
2
Stem Cell Transplantation
2
Mesna
2
Magnetic Resonance Spectroscopy
2
Filgrastim
2
treosulfan
1
selinexor
1
plerixafor
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Carmustine
×
90 days
×
Clear all
No trials found.